Today: 11 June 2026
SPY Holds the $667 Line as AI CapEx Booms and Fed Officials Cloud a December Cut — Weekend Market Wrap (Nov. 8, 2025)
8 November 2025
3 mins read

SPY Holds the $667 Line as AI CapEx Booms and Fed Officials Cloud a December Cut — Weekend Market Wrap (Nov. 8, 2025)

  • SPY finished Friday at $670.97 (intraday low $661.21), edging up ~0.1% on the day and stabilizing just above the $667 area many traders are watching. QQQ closed at $609.74 and the Nasdaq logged its worst week since April as AI leaders cooled.
  • Fed messaging turned more cautious: Chair Powell said a December rate cut is “not a foregone conclusion,” while Austan Goolsbee said he’s undecided, and Beth Hammack argued for a pause. Futures now imply roughly two‑thirds odds of a 25 bp cut next month. Reuters+4Reuters+4Reuters+4
  • AI spending remains enormous: Wall Street estimates put 2025 AI infrastructure CapEx near the high‑$300B to ~$400B range, with Citi projecting ~$490B in 2026 and $2.8T by 2029, underscoring why AI remains a core macro driver for equities.
  • Macro backdrop: Friday’s risk tone improved late on signs of progress in the U.S. government shutdown. The 10‑year yield hovered ~4.09% as the data vacuum persists.

What moved stocks on Friday

Stocks whipsawed but the S&P 500 and Dow finished slightly higher, while the Nasdaq slipped amid renewed skepticism about the durability of the AI rally. Late‑day reports of shutdown progress helped narrow losses. Treasury 10‑year yields dipped to about 4.09% into the close.

Meanwhile, SPY eked out a small gain as the session digested a sharp drop in consumer sentiment, ongoing tech volatility, and the long government shutdown that is still muting official data releases.


Fed watch: December cut now a coin toss—at best

  • Chair Jerome Powell: A December rate cut is “not a foregone conclusion”; policy remains data‑dependent. Markets recoiled when he tempered expectations after the most recent cut. Reuters
  • Chicago Fed’s Austan Goolsbee: “Not decided” on December; inflation progress is key, especially with limited data during the shutdown. Reuters
  • Cleveland Fed’s Beth Hammack: Warned the Fed should pause cuts for now, calling inflation the bigger risk.

Pricing in Fed funds futures has swung: depending on the hour and headline, traders have carried ~65%–71% odds of a 25‑bp cut in December—down from the >90% levels seen before Powell’s remarks. Expect that probability to bounce around next week.

Why it matters for SPY/QQQ: rate‑sensitive valuations—especially in long‑duration growth and AI beneficiaries—are most exposed when cut odds fade.


AI CapEx is still the big macro tailwind

Even with this week’s AI wobble, hyperscalers’ data‑center buildout remains massive. Industry and sell‑side tallies put 2025 AI infrastructure spending in the ~$380B–$400B zip code, and Citigroup now projects ~$490B in 2026 and $2.8T cumulatively by 2029. The scale explains why AI spending keeps showing up as a buffer for SPY earnings even when macro clouds gather.


Shutdown watch, yields, and the data vacuum

The longest federal shutdown on record has delayed key releases, forcing investors to lean on private surveys and market proxies. Friday’s late optimism around negotiations helped sentiment, while the 10‑year Treasury held near 4.09%.

Next macro catalyst: The BLS CPI for October is scheduled for Thursday, Nov. 13, 8:30 a.m. ET—a critical print for December policy odds.


Levels to watch

  • SPY: Friday’s $661 intraday low and $671 close define the near‑term box. A push above ~$685 reopens a run at the late‑October highs near $689, while $660–$662 is first support on dips.
  • QQQ: Closed $609.74 after a week‑low $598.67 on Friday; $600 is the psychological pivot and $622 (Thursday’s close) is first resistance on rebounds.

Week in review (Nov. 4–8)

  • Nasdaq −~3% for the week, its sharpest weekly slide since April, as leadership in AI heavyweights cooled. S&P 500 (SPX) and Dow clung to small Friday gains into the bell.
  • SPY −~1.8% on the week; QQQ −~3.5%, reflecting heavier pressure on mega‑cap tech.

What to watch next week

  • Inflation (CPI, Thu 11/13, 8:30 ET): The single biggest swing factor for December cut odds and for equity duration trades.
  • Fed speak: After Powell’s “not a foregone conclusion,” any additional signals from policymakers could jolt futures‑implied probabilities—and tech multiples with them. Reuters
  • Shutdown headlines: A concrete path to reopening would restore data flow and likely lift risk appetite at the margin.

By the numbers (Fri, Nov. 7, 2025)

  • SPY close:$670.97 (day +0.10%; week −1.8%). Range: $661.21–$671.08.
  • QQQ close:$609.74 (day −0.32%; week −3.5%). Range: $598.67–$609.95.
  • 10‑year U.S. Treasury:~4.09% into the close.

Context from today’s coverage and the sources you shared

  • SPY daily wrap (11/7): TipRanks highlighted the small Friday gain in SPY alongside weak consumer sentiment, tech volatility, and the shutdown’s drag on data.
  • “Cut in doubt” drumbeat: Powell’s caution, Goolsbee’s indecision, and Hammack’s call to pause collectively tempered expectations for an imminent cut. Reuters+2Reuters+2
  • AI CapEx backdrop: Street tallies cluster around $380B–$400B in 2025, with Citi pushing a $490B 2026 run‑rate and $2.8T cumulative by decade’s end.

Editor’s note: This article is a news analysis for Nov. 8, 2025, based on verified reporting and market data. It does not constitute investment advice.

Sources
Reuters market wrap & yields; Fed commentary (Powell/Goolsbee/Hammack); shutdown progress; futures‑implied odds; AI CapEx projections (Citi); TipRanks daily ETF notes; SPY/QQQ historical prices (Investing.com, StockAnalysis); BLS CPI calendar.

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Stock Market Today

  • Live Cattle Futures Edge Higher Amid Mixed USDA Beef Prices
    June 11, 2026, 10:54 AM EDT. Live cattle futures rose by $1.45 to $1.60 across most front months on Wednesday, with December delivery slightly down. Feeder cattle futures gained $2.40 to $2.90 by midday. Open interest increased by 1,293 contracts. Managed money trimmed net long positions in live cattle futures and options by 7,083 contracts, totaling 101,265, while feeder cattle spec funds reduced holdings by 470 contracts. USDA reported a decline in wholesale boxed beef prices, with Choice boxes down $1.68 to $359.36 and Select down $3.15 to $344.88. Federally inspected cattle slaughter rose to an estimated 123,000 head Wednesday, exceeding last week but falling short of last year. The mixed data signals ongoing volatility in cattle markets as traders assess supply and demand factors.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
IBM Stock Soars on Quantum Breakthrough and AI Revival – Key Updates (Sept 25, 2025)
Previous Story

IBM Stock Today (Nov. 7, 2025): Shares Slip 1.9% as Dow Weakens; DARPA Quantum Milestone and Red Hat Integration Dominate the Headlines

Anduril’s Fury (YFQ‑44A) Completes First Flight in 556 Days, Accelerating the Air Force’s CCA Program — What’s New Today (Nov. 10, 2025)
Next Story

Anduril’s Fury (YFQ‑44A) Completes First Flight in 556 Days, Accelerating the Air Force’s CCA Program — What’s New Today (Nov. 10, 2025)

Go toTop